Elekta AB Series B chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 38.91
Dividend & YieldN/A£ (N/A)
Beta 0.92
Market capitalization N/A
Operating cash flow 1.74B
ESG Scores unknown

Company description

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Sector: - Industry:

Financial data

Financial Statements

Cashflow Statement 2019-04-30 2020-04-30 2021-04-30 2022-04-30
Change To Liabilities
Total Cashflows From Investing Activities -674M -1.3B -613M -1.65B
Net Borrowings -938M 3.31B -2.92B -886M
Total Cash From Financing Activities -1.47B 2.62B -3.6B -1.73B
Change To Operating Activities -249M -962M 393M 376M
Issuance Of Stock
Net Income 1.2B 1.08B 1.25B 1.15B
Change In Cash -385M 2.33B -2B -1.33B
Effect Of Exchange Rate 142M -5M -329M 183M
Total Cash From Operating Activities 1.62B 1.01B 2.55B 1.86B
Depreciation 279M 537M 519M 546M
Change To Account Receivables -367M -434M -772M -291M
Other Cashflows From Financing Activities 1M 1M -2.92B 1M
Change To Netincome 116M 167M 202M -323M
Capital Expenditures -201M -196M -167M -188M

Income Statement 2019-04-30 2020-04-30 2021-04-30 2022-04-30
Research Development 1.59B 1.66B 1.49B 1.37B
Income Before Tax 1.58B 1.45B 1.63B 1.5B
Net Income 1.2B 1.08B 1.25B 1.15B
Selling General Administrative 2.33B 2.54B 2.23B 2.53B
Gross Profit 5.68B 6.14B 5.61B 5.44B
Ebit 1.78B 1.89B 1.81B 1.49B
Operating Income 1.78B 1.89B 1.81B 1.49B
Interest Expense -156M -214M -277M -148M
Income Tax Expense 382M 370M 377M 345M
Total Revenue 13.55B 14.6B 13.76B 14.55B
Cost Of Revenue 7.88B 8.46B 8.15B 9.11B
Total Other Income ExpenseNet -198M -435M -180M 13M
Net Income From Continuing Ops 1.2B 1.08B 1.25B 1.16B
Net Income Applicable To Common Shares 1.2B 1.08B 1.25B 1.15B

Balance Sheet Statement 2019-04-30 2020-04-30 2021-04-30 2022-04-30
Total Liabilities 16.29B 20.3B 16.65B 17.39B
Total Stockholder Equity 7.78B 8.11B 8.2B 8.91B
Other Current Liabilities 8.35B 7.51B 6.82B 7.85B
Total Assets 24.06B 28.41B 24.84B 26.3B
Common Stock 192M 192M 8.2B 192M
Other Current Assets 172M 265M -2M 211M
Retained Earnings 5.56B 5.83B 6.57B 6.88B
Treasury Stock 1.22B 1.28B 625M 1.03B
Cash 4.07B 6.41B 4.41B 3.08B
Total Current Liabilities 11.9B 11.3B 11.94B 11.56B
Other Stockholder Equity 1.22B 1.28B 625M 1.03B
Property, Plant, and Equipment 957M 2.12B 1.85B 1.93B
Total Current Assets 12.9B 15.57B 13.25B 12.88B
Net Tangible Assets 694M 719M -582M 1.47B
Net Receivables 5.49B 5.6B 6.55B 6.35B
Accounts Payable 1.43B 1.02B 1.02B 1.35B


Insider Transactions

Here are the insider transactions of stock shares related to Elekta AB Series B:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Elekta AB Series B. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Elekta AB Series B

Here is the result of two systematic investment strategies applied to Elekta AB Series B. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Elekta AB Series B

The following chart shows the equity curve of the two systematic investment strategies applied to Elekta AB Series B:

Elekta AB Series B automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 0% on the backtest period.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

0.0 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Elekta AB Series B

This is the result of two momentum investment strategies applied to Elekta AB Series B. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Elekta AB Series B

The following chart shows all the entries opened by the momentum investment system on Elekta AB Series B:

Elekta AB Series B momentum entries
  • The first momentum investment strategy would give 0.0% of return on Elekta AB Series B. That represents 0.0£ of latent gain with 295.02£ of employed capital.
  • The second momentum investment strategy would give 0% of return on Elekta AB Series B. That represents 0.0£ of latent gain with 0.0£ of employed capital.
Performance at glance (1Q Momentum)

Performance

0.0 %

Latent gain

0.0 £

Invested capital

295.02 £

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Momentum equity curve on Elekta AB Series B

The following chart shows the equity curve of the two momentum strategies applied to Elekta AB Series B:

Elekta AB Series B momentum equity

Note: the dividends potentially given by Elekta AB Series B are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Elekta AB Series B

The following chart shows the employed capital evolution of the two momentum strategies on Elekta AB Series B since the beginning:

Elekta AB Series B

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on Elekta AB Series B

Buy the dip entry openings on Elekta AB Series B

Elekta AB Series B

The performance achieved by the robo-advisor on Elekta AB Series B is 0%. That represents 0.0$ of latent gain with 0.0£ of employed capital. The following chart shows Elekta AB Series B stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Elekta AB Series B, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Equity curve of the strategy applied to Elekta AB Series B

The following chart shows the result of the investment strategy applied to Elekta AB Series B:

Elekta AB Series B

Note: the dividends potentially given by Elekta AB Series B are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Elekta AB Series B

The following chart shows the employed capital evolution since the beginning of the investment strategy on Elekta AB Series B:

Elekta AB Series B

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Elekta AB Series B

In this section, I will compare the three previous investment strategies applied to Elekta AB Series B.

Equity curve comparison on Elekta AB Series B

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Elekta AB Series B investment strategy comparison

Employed capital comparison on Elekta AB Series B

Elekta AB Series B investment comparison

Performance comparison on Elekta AB Series B

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 0% 0.0£ 0.0£ 0.0%
Momentum 1 quarter 0.0% 0.0£ 295.02£ 0.0%
Momentum 2 quarters 0% 0.0£ 0.0£ -0.0%
Non-directional 0% 0.0£ 0.0£ -0.0%
Annualized return comparison

Automatic investment

0.0 %

Momentum 1Q

-0.0 %

Momentum 2Q

-0.0 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Elekta AB Series B:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Elekta AB Series B and the other stocks. There may be false positives or some missing correlated stocks. If the price of Elekta AB Series B does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Elekta AB Series B
Country Sweden
City Stockholm
Address Kungstensgatan 18
Phone 46 8 58 72 54 00
Website www.elekta.com
FullTime employees 4700
Industry
Sector
Exchange XLON
Ticker 0O5H.XLON
Market www.londonstockexchange.com

Elekta AB Series B ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown